BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 12204004)

  • 1. Human piebaldism: six novel mutations of the proto-oncogene KIT.
    Syrris P; Heathcote K; Carrozzo R; Devriendt K; Elçioglu N; Garrett C; McEntagart M; Carter ND
    Hum Mutat; 2002 Sep; 20(3):234. PubMed ID: 12204004
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel KIT missense mutation in one Chinese family with piebaldism.
    Yin XY; Ren YQ; Yang S; Xu SX; Zhou FS; Du WH; Lin D; Wang PG; Zhang SM; Zhang XJ
    Arch Dermatol Res; 2009 Jun; 301(5):387-9. PubMed ID: 19430803
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New KIT mutations in patients with piebaldism.
    Murakami T; Fukai K; Oiso N; Hosomi N; Kato A; Garganta C; Barnicoat A; Poppelaars F; Aquaron R; Paller AS; Ishii M
    J Dermatol Sci; 2004 Jun; 35(1):29-33. PubMed ID: 15194144
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel KIT mutation results in piebaldism with progressive depigmentation.
    Richards KA; Fukai K; Oiso N; Paller AS
    J Am Acad Dermatol; 2001 Feb; 44(2):288-92. PubMed ID: 11174389
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A novel KIT gene mutation results in piebaldism].
    Deng WP; Lu C; Zhu GX; Lin QD; Feng PY
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2005 Oct; 22(5):545-7. PubMed ID: 16220461
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A novel KIT gene mutation from a family with piebaldism in the southern part of China].
    Deng WP; Huang YS; Lu C; Lan W; Zhu GX; Lin QD; Feng PY
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2005 Dec; 22(6):668-70. PubMed ID: 16331568
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human piebald trait resulting from a dominant negative mutant allele of the c-kit membrane receptor gene.
    Fleischman RA
    J Clin Invest; 1992 Jun; 89(6):1713-7. PubMed ID: 1376329
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel mutation of the KIT gene in a Chinese family with piebaldism.
    Wen GD; Zhou C; Yu C; DU J; Xu QX; Liu ZY; Zhang JZ
    Chin Med J (Engl); 2013 Jun; 126(12):2325-8. PubMed ID: 23786947
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Piebaldism and neurofibromatosis type 1: family report.
    Duarte AF; Mota A; Baudrier T; Morais P; Santos A; Cerqueira R; Tavares P; Azevedo F
    Dermatol Online J; 2010 Jan; 16(1):11. PubMed ID: 20137753
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New mutations of KIT gene in two Chinese patients with piebaldism.
    Lin ZM; Xu Z; Bu DF; Yang Y
    Br J Dermatol; 2006 Dec; 155(6):1303-4. PubMed ID: 17107413
    [No Abstract]   [Full Text] [Related]  

  • 11. Two children with a mild or moderate piebaldism phenotype and a father without leukoderma in a family with the same recurrent missense mutation in the kinase domain of KIT.
    Narita T; Oiso N; Fukai K; Motokawa T; Hayashi M; Yokoyama K; Hozumi Y; Kawada A; Suzuki T
    Eur J Dermatol; 2011; 21(3):446-7. PubMed ID: 21680281
    [No Abstract]   [Full Text] [Related]  

  • 12. Three novel mutations of the proto-oncogene KIT cause human piebaldism.
    Syrris P; Malik NM; Murday VA; Patton MA; Carter ND; Hughes HE; Metcalfe K
    Am J Med Genet; 2000 Nov; 95(1):79-81. PubMed ID: 11074500
    [No Abstract]   [Full Text] [Related]  

  • 13. Molecular characterization of two novel KIT mutations in patients with piebaldism.
    Wasag B; Chmara M; Legius E
    J Dermatol Sci; 2012 Apr; 66(1):78-9. PubMed ID: 22264755
    [No Abstract]   [Full Text] [Related]  

  • 14. Molecular characterization of piebaldism in a Tunisian family.
    Kerkeni E; Boubaker S; Sfar S; Bizid M; Besbes H; Bouaziz S; Ghedira N; Amara A; Manoubi W; Gribaa M; Monastiri K
    Pathol Biol (Paris); 2015 Jun; 63(3):113-6. PubMed ID: 25910686
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human malignant melanoma: detection of BRAF- and c-kit-activating mutations by high-resolution amplicon melting analysis.
    Willmore-Payne C; Holden JA; Tripp S; Layfield LJ
    Hum Pathol; 2005 May; 36(5):486-93. PubMed ID: 15948115
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutations in the ligand-binding domain of the kit receptor: an uncommon site in human piebaldism.
    Fleischman RA; Gallardo T; Mi X
    J Invest Dermatol; 1996 Nov; 107(5):703-6. PubMed ID: 8875953
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Specific c-kit mutations in sinonasal natural killer/T-cell lymphoma in China and Japan.
    Hongyo T; Li T; Syaifudin M; Baskar R; Ikeda H; Kanakura Y; Aozasa K; Nomura T
    Cancer Res; 2000 May; 60(9):2345-7. PubMed ID: 10811105
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Seven novel KIT mutations in horses with white coat colour phenotypes.
    Haase B; Brooks SA; Tozaki T; Burger D; Poncet PA; Rieder S; Hasegawa T; Penedo C; Leeb T
    Anim Genet; 2009 Oct; 40(5):623-9. PubMed ID: 19456317
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel splicing mutation of KIT results in piebaldism and auburn hair color in a Chinese family.
    Yang YJ; Zhao R; He XY; Li LP; Wang KW; Zhao L; Tu M; Tang JS; Xie ZG; Zhu YM
    Biomed Res Int; 2013; 2013():689756. PubMed ID: 24000325
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiple novel alterations in Kit tyrosine kinase in patients with gastrointestinally pronounced systemic mast cell activation disorder.
    Molderings GJ; Kolck UW; Scheurlen C; Brüss M; Homann J; Von Kügelgen I
    Scand J Gastroenterol; 2007 Sep; 42(9):1045-53. PubMed ID: 17710669
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.